thiazoles has been researched along with Venous Thrombosis in 69 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (2.90) | 29.6817 |
| 2010's | 60 (86.96) | 24.3611 |
| 2020's | 7 (10.14) | 2.80 |
| Authors | Studies |
|---|---|
| Ajiki, T; Fukumoto, T; Gon, H; Kido, M; Mizumoto, T; So, S; Toyama, H; Tsugawa, D; Ueshima, E; Yanagimoto, H | 1 |
| Fioretti, AM; Giotta, F; Leopizzi, T; Lorusso, V; Luzzi, G; Oliva, S; Puzzovivo, A | 1 |
| Ando, M; Chihara, H; Hatano, T; Higashi, E; Kamata, T; Kondo, D; Nagata, I; Ogura, T; Sakai, S; Sakamoto, H; Suzuki, K; Yamagami, K | 1 |
| Ageno, W; Casella, IB; Chee, KH; Desch, M; Donado, E; Goldhaber, SZ; Reilly, PA; Schellong, S; Schulman, S; Singer, DE; Tang, W; Voccia, I | 1 |
| Aballi, S; Bergan, J; Fronas, S; Garabet, L; Ghanima, W; Overstad, S; Tjonnfjord, E | 1 |
| Hara, N; Motoyama, A; Ouchi, A; Sugiyama, Y; Takamoto, T; Tanaka, R; Tsuchiya, T; Yanagawa, Y | 1 |
| Furuta, K; Ishii, K; Kobayashi, M; Morishita, E; Saito, K; Wada, Y | 1 |
| Aprile, F; Breccia, M; Chistolini, A; Fiori, L; Gioia, S; Lucani, B; Merli, M; Riggio, O; Serrao, A | 1 |
| Cifu, AS; Jain, A | 1 |
| Hashimoto, S; Hayashi, S; Ishida, K; Kodato, K; Kuroda, R; Kurosaka, M; Matsumoto, T; Oka, S; Shibanuma, N; Takayama, K; Toda, A | 1 |
| Kamata, F; Kamata, M; Murano, J; Nagaba, H; Nagaba, Y; Nonoguchi, H; Okina, C; Shimada, H; Shimada, Y; Takeuchi, Y | 1 |
| Fujimoto, N; Hasegawa, M; Ikejiri, M; Katayama, N; Matsumoto, T; Ohishi, K; Sudo, A; Tone, S; Wada, H; Wakabayashi, H; Watanabe, M; Yamaguchi, T; Yamashita, Y | 1 |
| Akamatsu, Y; Hirotomi, K; Kobayashi, H; Kumagai, K; Kusayama, Y; Okuyama, H; Saito, T; Shinohara, K | 1 |
| Aihara, S; Fukumitsu, K; Harada, A; Hiramatsu, Y; Hirashima, Y; Iwata, R; Kamimura, T; Kondo, M; Oka, H; Tsuruya, K | 1 |
| Ci, H; Ge, X; Song, W; Tian, G; Zhang, Y | 1 |
| Kroeger, K; Kujath, P | 1 |
| Avorn, J; Choudhry, NK; Gagne, JJ; Glynn, RJ; Krumme, AA; Kulldorff, M; Ortiz, AS; Pawar, A; Schneeweiss, S | 1 |
| Hu, Y; Tang, L; Zhang, Z | 1 |
| Fujino, T; Hamai, A; Hara, F; Harada, M; Ikeda, T; Kabuki, T; Ohara, H; Wakakura, S | 1 |
| Mukai, Y; Nozawa, S; Suzuki, T | 1 |
| Oung, AB | 1 |
| Fiorelli, EM; Rossi, RE | 1 |
| Carrier, M; Khorana, AA; Lee, AYY; Meyer, G; Noble, S; O'Connell, C; Soff, G | 1 |
| Hiroshima, R; Ikari, K; Ishibashi, M; Mochizuki, T; Okazaki, K; Yano, K | 1 |
| Akaboshi, S; Fujita, H; Inoue, M; Kada, A; Kaneko, H; Kawasaki, M; Koretsune, Y; Kumode, M; Maruhashi, K; Miyanomae, T; Murata, H; Nakamura, M; Ohmori, H; Okumura, A; Saito, AM; Sanayama, Y; Sano, N; Shinagawa, T; Sone, S; Sumimoto, R; Takechi, T; Takizawa, N; Taniguchi, H; Tanuma, N; Wakisaka, A | 1 |
| Hashimoto, S; Hayashi, S; Ishida, K; Kodato, K; Kuroda, R; Kurosaka, M; Matsumoto, T; Matsushita, T; Niikura, T; Sasaki, H; Shibanuma, N; Takayama, K; Toda, A | 1 |
| Själander, A; Själander, S | 1 |
| Abe, H; Doi, T; Inagaki, T; Kishi, F; Kishi, S; Minato, M; Murakami, T; Nagai, K; Nishimura, K; Obata, F; Ono, H; Shibata, E; Tamaki, M; Ueda, S | 1 |
| Fujisawa, H; Shimizu, Y; Tsuchiya, K | 1 |
| Abe, T; Hasegawa, I; Itoh, Y; Mino, T; Okamoto, K; Takeda, A | 1 |
| Buller, H; Carrier, M; Di Nisio, M; Garcia, D; Raskob, G; Segers, A; van Es, N; Wang, TF; Weitz, J | 1 |
| Nieto Rodríguez, JA | 1 |
| Fukuda, T; Furugohri, T; Honda, Y; Kamisato, C; Kojima, T; Matsushita, T; Morishima, Y; Shibano, T | 1 |
| Ishida, K; Kuroda, R; Kurosaka, M; Matsumoto, T; Sasaki, H; Shibanuma, N; Tateishi, H; Tei, K; Toda, A; Yamashiro, Y | 1 |
| Einecke, D | 1 |
| Rondina, MT; Vazquez, S; Vo, T | 1 |
| Giugliano, RP; Plitt, A | 1 |
| Yorozu, T | 1 |
| Andersen, JF; Lauritsen, ML; Wilhelmsen, M | 1 |
| Ansell, J; Mantha, S | 1 |
| Fuji, T; Fujita, S; Kawai, Y; Kimura, T; Tachibana, S; Wang, CJ | 1 |
| Honda, Y; Kamisato, C; Morishima, Y | 1 |
| Aota, T; Asanuma, K; Hasegawa, M; Katayama, N; Matsumoto, T; Miyamoto, N; Naitoh, K; Nishikawa, M; Ohishi, K; Shimokariya, Y; Sudo, A; Uchida, A; Wada, H; Wakabayashi, H; Yamada, N; Yamashita, Y; Yoshida, K | 1 |
| Amin, A; Deitelzweig, S | 1 |
| Ito, M; Nakamura, M; Yamada, N | 1 |
| Alie, N; Besa, C; Fayad, ZA; Goldhaber, SZ; Grosso, M; Mani, V; Mercuri, M; Piazza, G; Ramachandran, S; Robson, PM; Taouli, B | 1 |
| Kesteven, P; McCaslin, JE; Robertson, L | 2 |
| Abe, K; Büller, H; Kimura, T; Lee, LH; Mercuri, M; Miyazaki, K; Nakamura, M; Oh, D; Segers, A; Wang, C; Wang, YQ; Yin, WH | 1 |
| Jönsson, S; Karlsson, MO; Krekels, EH; Miller, R; Niebecker, R; Nyberg, J; Simonsson, US | 1 |
| Beyer-Westendorf, J; Bleker, SM; Boda, Z; Büller, HR; Carrier, M; Chlumsky, J; Décousus, H; Di Nisio, M; Garcia, D; Gibbs, H; Grosso, MA; Kakkar, A; Kamphuisen, PW; Mercuri, MF; Monreal, M; Ockelford, P; Pabinger, I; Raskob, GE; Schwocho, L; Segers, A; van Es, N; Verhamme, P; Weitz, JI | 1 |
| Dhillon, S; Shirley, M | 1 |
| Roca, B; Roca, M | 1 |
| Asahara, T; Izumi, M; Jiuchi, Y; Kidera, K; Kozuru, H; Kumagai, K; Mawatari, M; Migita, K; Motokawa, S; Osaki, M; Sakai, T; Yamaguchi, T | 1 |
| Stiefelhagen, P | 1 |
| Enomoto, Y; Iida, H; Iwama, T; Kito, Y; Kozawa, O; Kuroyanagi, G; Matsushima-Nishiwaki, R; Ogura, S; Otsuka, T; Tokuda, H; Tsujimoto, M | 1 |
| Dobesh, PP; Finks, SW; Trujillo, TC | 1 |
| Cannon, K; Chinigo, A; Concha, M; Fayad, ZA; Goldhaber, SZ; Grosso, MA; Hsu, C; Lanz, HJ; Mani, V; Mercuri, M; Nadar, V; Piazza, G; Pullman, J; Ritchie, B; Schul, M; Schussler, S | 1 |
| Jönsson, S; Karlsson, KE; Karlsson, MO; Miller, R; Nyberg, J; Simonsson, U; Yin, O | 1 |
| Davies, AH; Lim, CS; Ravikumar, R | 1 |
| Bocanegra, T; Cohen, AT; Eriksson, BI; Puskas, D; Raskob, G; Shi, M; Weitz, JI | 1 |
| Morishima, Y; Shibano, T | 1 |
| Hiroe, K; Kawamura, M; Konishi, N | 1 |
| Bounameaux, H; Camm, AJ | 1 |
| Edo, N; Honda, Y; Kamisato, C; Kita, A; Morishima, Y; Shibano, T; Tsuji, N | 1 |
| Almond, HR; Andrade-Gordon, P; Corcoran, TW; Costanzo, MJ; de Garavilla, L; Giardino, EC; Haertlein, BJ; Hecker, LR; Kauffman, JA; Lewis, JM; Maryanoff, BE; Schott, MR; Yabut, SC; Zhang, HC | 1 |
| Hollenbach, SJ; Ku, P; Lin, PH; Malinowski, J; Marlowe, CK; Scarborough, RM; Sinha, U; Wong, PW; Zhu, BY | 1 |
17 review(s) available for thiazoles and Venous Thrombosis
| Article | Year |
|---|---|
Edoxaban: front-line treatment for brachiocephalic vein thrombosis in primitive mediastinal seminoma: A case report and literature review.
Topics: Adult; Anticoagulants; Brachiocephalic Veins; Enoxaparin; Heparin, Low-Molecular-Weight; Humans; Male; Pyridines; Seminoma; Testicular Neoplasms; Thiazoles; Thrombosis; Venous Thrombosis | 2022 |
Progress in the research on venous thromboembolism.
Topics: Anticoagulants; Blood Coagulation Factors; Computed Tomography Angiography; Dabigatran; Genetic Predisposition to Disease; Heparin; Humans; Phlebography; Practice Guidelines as Topic; Pulmonary Embolism; Pyridines; Quality of Life; Recurrence; Risk Factors; Thiazoles; Venous Thromboembolism; Venous Thrombosis | 2017 |
[New approaches in the treatment of deep vein thrombosis].
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Biotin; Clinical Trials, Phase III as Topic; Dabigatran; Drug Administration Schedule; Humans; Morpholines; Oligosaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Venous Thrombosis | 2012 |
Current state of anticoagulants to treat deep venous thrombosis.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Medication Adherence; Morpholines; Patient Selection; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Venous Thrombosis | 2014 |
Edoxaban: Review of pharmacology and key phase I to III clinical trials.
Topics: Anticoagulants; Atrial Fibrillation; Clinical Trials as Topic; Factor Xa Inhibitors; Hemorrhage; Humans; Pyridines; Randomized Controlled Trials as Topic; Thiazoles; Treatment Outcome; Venous Thrombosis; Warfarin | 2014 |
[Prevention of venous thromboembolism and anticoagulant therapy].
Topics: Anesthesia, Epidural; Anticoagulants; Biomarkers; Diagnostic Imaging; Fibrin Fibrinogen Degradation Products; Heparin; Humans; Intraoperative Complications; Perioperative Care; Postoperative Complications; Practice Guidelines as Topic; Pulmonary Embolism; Pyridines; Risk Factors; Thiazoles; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2014 |
Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism.
Topics: Acute Disease; Adult; Aged; Anticoagulants; Clinical Trials, Phase III as Topic; Dabigatran; Female; Hemorrhage; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Recurrence; Risk Assessment; Rivaroxaban; Survival Analysis; Thiazoles; Venous Thrombosis | 2015 |
Target-specific oral anticoagulants and the hospitalist.
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Clinical Trials, Phase III as Topic; Dabigatran; Factor Xa Inhibitors; Hospitalists; Humans; International Normalized Ratio; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Venous Thrombosis; Warfarin | 2015 |
Current management of venous thromboembolism in Japan: Current epidemiology and advances in anticoagulant therapy.
Topics: Anticoagulants; Fondaparinux; Heparin; Humans; Japan; Polysaccharides; Pulmonary Embolism; Pyridines; Quality of Life; Risk Factors; Thiazoles; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2015 |
Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis.
Topics: Administration, Oral; Antithrombins; Azetidines; Benzylamines; Dabigatran; Factor Xa Inhibitors; Humans; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiazoles; Venous Thrombosis | 2015 |
Edoxaban: A Review in Deep Vein Thrombosis and Pulmonary Embolism.
Topics: Factor Xa Inhibitors; Humans; Pulmonary Embolism; Pyridines; Thiazoles; Venous Thrombosis | 2015 |
Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism.
Topics: Administration, Oral; Anticoagulants; Antithrombins; Dabigatran; Factor Xa Inhibitors; Humans; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Recurrence; Rivaroxaban; Secondary Prevention; Thiazoles; Venous Thromboembolism; Venous Thrombosis | 2015 |
The new oral anticoagulants: Reasonable alternatives to warfarin.
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Venous Thrombosis | 2015 |
Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy.
Topics: Administration, Oral; Anticoagulants; Dabigatran; Drug Interactions; Humans; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiazoles; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis | 2016 |
The Role of New Oral Anticoagulants (NOACs) in Cancer Patients.
Topics: Administration, Oral; Anticoagulants; Antithrombins; Catheters, Indwelling; Dabigatran; Drug Administration Schedule; Drug Dosage Calculations; Humans; Neoplasms; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiazoles; Venous Thromboembolism; Venous Thrombosis | 2017 |
[Research and development strategy of antithrombotic agents: pharmacology of the oral factor Xa-inhibitor edoxaban].
Topics: Administration, Oral; Animals; Atrial Fibrillation; Clinical Trials, Phase III as Topic; Drug Design; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Intracranial Thrombosis; Postoperative Complications; Pyridines; Secondary Prevention; Thiazoles; Thrombosis; Venous Thrombosis | 2010 |
[Do orally active factor Xa (FXa) inhibitors have potential as innovative new anticoagulants? Future perspective from preclinical data].
Topics: Animals; Anticoagulants; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Factor Xa Inhibitors; Humans; Intracranial Thrombosis; Macaca fascicularis; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Venous Thrombosis | 2010 |
15 trial(s) available for thiazoles and Venous Thrombosis
| Article | Year |
|---|---|
Monitoring of hemostatic abnormalities in major orthopedic surgery patients treated with edoxaban by APTT waveform.
Topics: Aged; Drug Monitoring; Hemorrhage; Humans; Male; Middle Aged; Orthopedic Procedures; Partial Thromboplastin Time; Pyridines; Thiazoles; Venous Thromboembolism; Venous Thrombosis | 2018 |
Edoxaban is effective in reducing the incidence of asymptomatic phlebographic events following closed-wedge high tibial osteotomy.
Topics: Aged; Factor Xa Inhibitors; Female; Fibrin Fibrinogen Degradation Products; Hemorrhage; Humans; Male; Middle Aged; Osteotomy; Partial Thromboplastin Time; Phlebography; Postoperative Complications; Postoperative Period; Prospective Studies; Pyridines; Thiazoles; Tibia; Tomography, X-Ray Computed; Venous Thromboembolism; Venous Thrombosis | 2017 |
Multicenter, Open-Label, Randomized Controlled Trial of Warfarin and Edoxaban Tosilate Hydrate for the Treatment of Deep Vein Thrombosis in Persons with Severe Motor Intellectual Disabilities.
Topics: Anticoagulants; Factor Xa Inhibitors; Hemorrhage; Humans; Intellectual Disability; Intelligence; Japan; Motor Activity; Motor Disorders; Multicenter Studies as Topic; Persons with Mental Disabilities; Pyridines; Randomized Controlled Trials as Topic; Thiazoles; Time Factors; Treatment Outcome; Venous Thrombosis; Warfarin | 2018 |
A prospective randomized comparative study to determine appropriate edoxaban administration period, to prevent deep vein thromboembolism in patients with total knee arthroplasty.
Topics: Aged; Aged, 80 and over; Arthritis; Arthroplasty, Replacement, Knee; Drug Administration Schedule; Factor Xa Inhibitors; Female; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Prospective Studies; Pyridines; Thiazoles; Venous Thromboembolism; Venous Thrombosis | 2018 |
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study.
Topics: Aged; Blood Coagulation; Dalteparin; Drug Administration Schedule; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Neoplasms; Prospective Studies; Pulmonary Embolism; Pyridines; Recurrence; Risk Factors; Thiazoles; Time Factors; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis | 2019 |
Safety and efficacy of edoxaban, an oral factor xa inhibitor, for thromboprophylaxis after total hip arthroplasty in Japan and Taiwan.
Topics: Aged; Antithrombins; Arthroplasty, Replacement, Hip; Double-Blind Method; Enoxaparin; Factor Xa Inhibitors; Female; Humans; Japan; Male; Middle Aged; Pyridines; Taiwan; Thiazoles; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis | 2014 |
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis.
Topics: Contrast Media; Gadolinium; Humans; Leg; Magnetic Resonance Angiography; Organometallic Compounds; Pelvis; Pyridines; Reproducibility of Results; Thiazoles; Venous Thrombosis | 2015 |
Efficacy and safety of edoxaban for treatment of venous thromboembolism: a subanalysis of East Asian patients in the Hokusai-VTE trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Asia, Eastern; Asian People; Double-Blind Method; Factor Xa Inhibitors; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Pulmonary Embolism; Pyridines; Recurrence; Therapeutic Equivalency; Thiazoles; Venous Thromboembolism; Venous Thrombosis; Vitamin K; Warfarin; Young Adult | 2015 |
Population pharmacokinetics of edoxaban in patients with symptomatic deep-vein thrombosis and/or pulmonary embolism--the Hokusai-VTE phase 3 study.
Topics: Adolescent; Adult; Aged; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Models, Biological; Pulmonary Embolism; Pyridines; Thiazoles; Venous Thrombosis | 2015 |
Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study.
Topics: Adult; Anticoagulants; Dalteparin; Double-Blind Method; Factor Xa Inhibitors; Hemorrhage; Humans; Neoplasms; Prospective Studies; Pulmonary Embolism; Pyridines; Recurrence; Research Design; Sample Size; Thiazoles; Time Factors; Treatment Outcome; Venous Thrombosis | 2015 |
Effects of a Foot Pump on the Incidence of Deep Vein Thrombosis After Total Knee Arthroplasty in Patients Given Edoxaban: A Randomized Controlled Study.
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Body Mass Index; Female; Humans; Incidence; Japan; Male; Physical Therapy Modalities; Postoperative Complications; Pulmonary Embolism; Pyridines; Sex Factors; Thiazoles; Venous Thrombosis | 2016 |
Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Anticoagulants; Blood Coagulation; Drug Therapy, Combination; Factor Xa Inhibitors; Feasibility Studies; Female; Heparin; Humans; International Normalized Ratio; Magnetic Resonance Angiography; Male; Middle Aged; Phlebography; Predictive Value of Tests; Pyridines; Thiazoles; Time Factors; Treatment Outcome; United States; Venous Thrombosis; Warfarin | 2016 |
Edoxaban Exposure-Response Analysis and Clinical Utility Index Assessment in Patients With Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism.
Topics: Aged; Double-Blind Method; Drug Dosage Calculations; Factor Xa Inhibitors; Female; Humans; Male; Pulmonary Embolism; Pyridines; Risk Assessment; Thiazoles; Venous Thrombosis; Warfarin | 2016 |
Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
Topics: Administration, Oral; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Canada; Dalteparin; Double-Blind Method; Drug Administration Schedule; Elective Surgical Procedures; Europe; Factor Xa; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Hemorrhage; Humans; Injections, Subcutaneous; Logistic Models; Male; Middle Aged; Phlebography; Pulmonary Embolism; Pyridines; Risk Assessment; Risk Factors; Thiazoles; Time Factors; Treatment Outcome; United States; Venous Thromboembolism; Venous Thrombosis | 2010 |
Comparison of antithrombotic and haemorrhagic effects of edoxaban, an oral direct factor Xa inhibitor, with warfarin and enoxaparin in rats.
Topics: Administration, Oral; Animals; Anticoagulants; Enoxaparin; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Hemostatics; Male; Pyridines; Rats; Rats, Wistar; Thiazoles; Treatment Outcome; Venous Thrombosis; Warfarin | 2012 |
37 other study(ies) available for thiazoles and Venous Thrombosis
| Article | Year |
|---|---|
Successful recanalization of completely obstructed portal vein thrombosis after right hepatectomy for perihilar cholangiocarcinoma by aspiration thrombectomy via the ileocolic mesenteric vein and subsequent systemic anticoagulation with edoxaban.
Topics: Aged, 80 and over; Anticoagulants; Bile Duct Neoplasms; Bilirubin; Female; Hepatectomy; Humans; Klatskin Tumor; Liver Diseases; Mesenteric Veins; Portal Vein; Pyridines; Thiazoles; Thrombectomy; Thrombosis; Urokinase-Type Plasminogen Activator; Venous Thrombosis | 2022 |
Thrombosis of Large Aneurysm Induced by Flow-Diverter Stent and Dissolved by Direct Factor Xa Inhibitor.
Topics: Abducens Nerve Diseases; Carotid Artery Diseases; Carotid Artery, Internal; Factor Xa Inhibitors; Female; Humans; Intracranial Aneurysm; Intracranial Thrombosis; Leg; Middle Aged; Postoperative Complications; Pyridines; Stents; Thiazoles; Venous Thrombosis | 2019 |
Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study.
Topics: Administration, Oral; Adult; Age Distribution; Aged; Anticoagulants; Asia; Comorbidity; Cross-Sectional Studies; Dabigatran; Diabetes Mellitus; Europe; Factor Xa Inhibitors; Female; Fondaparinux; Heparin; Humans; Hypertension; Latin America; Male; Middle Aged; Middle East; Neoplasms; Postoperative Complications; Practice Patterns, Physicians'; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Venous Thromboembolism; Venous Thrombosis; Wounds and Injuries | 2020 |
Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases.
Topics: Adult; Ambulatory Care; Bed Rest; COVID-19; Factor Xa Inhibitors; Humans; Male; Middle Aged; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Risk Factors; Thiazoles; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis | 2020 |
Cerebral venous thrombosis in COVID-19-associated coagulopathy: A case report.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Fibrin Fibrinogen Degradation Products; Heparin; Humans; Intracranial Thrombosis; Magnetic Resonance Imaging; Male; Middle Aged; Pandemics; Pneumonia, Viral; Pyridines; SARS-CoV-2; Thiazoles; Tomography, X-Ray Computed; Venous Thrombosis | 2020 |
Recurrent Cerebral Venous Thrombosis Treated with Direct Oral Anticoagulants in a Japanese Man with Hereditary Protein C Deficiency.
Topics: Administration, Oral; Adult; Drug Substitution; Factor Xa Inhibitors; Heterozygote; Humans; Intracranial Thrombosis; Male; Mutation; Protein C; Protein C Deficiency; Pyridines; Recurrence; Thiazoles; Treatment Outcome; Venous Thrombosis | 2021 |
Outcomes of long-term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis.
Topics: Acenocoumarol; Adult; Anticoagulants; Budd-Chiari Syndrome; Duration of Therapy; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Mesenteric Ischemia; Middle Aged; Portal Vein; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Secondary Prevention; Thiazoles; Venous Thrombosis; Warfarin | 2021 |
Antithrombotic Therapy for Venous Thromboembolic Disease.
Topics: Antithrombins; Dabigatran; Humans; Practice Guidelines as Topic; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Review Literature as Topic; Rivaroxaban; Thiazoles; Venous Thromboembolism; Venous Thrombosis; Vitamin K | 2017 |
Prothrombin time-international normalized ratio is a useful marker for edoxaban efficacy in preventing venous thromboembolism after total knee arthroplasty.
Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Knee; Biomarkers; Early Ambulation; Factor Xa Inhibitors; Female; Humans; International Normalized Ratio; Male; Postoperative Complications; Postoperative Period; Pre-Exposure Prophylaxis; Prospective Studies; Prothrombin Time; Pyridines; ROC Curve; Thiazoles; Ultrasonography, Doppler, Color; Venous Thromboembolism; Venous Thrombosis | 2018 |
Edoxaban was Effective for Treating Renal Vein Thrombosis in a Patient with Nephrotic Syndrome.
Topics: Adult; Factor Xa Inhibitors; Heparin; Humans; Male; Nephrotic Syndrome; Pulmonary Embolism; Pyridines; Renal Veins; Thiazoles; Treatment Outcome; Venous Thrombosis; Warfarin | 2017 |
Cholesterol Crystal Embolism Induced by Direct Factor Xa Inhibitor: A First Case Report.
Topics: Aged, 80 and over; Anticoagulants; Embolism, Cholesterol; Factor Xa Inhibitors; Humans; Male; Middle Aged; Pyridines; Renal Insufficiency; Thiazoles; Toes; Tretoquinol; Venous Thrombosis | 2018 |
Edoxaban improves venous thrombosis via increasing hydrogen sulfide and homocysteine in rat model.
Topics: Animals; Anticoagulants; Chlorides; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelial Cells; Ferric Compounds; Gene Expression Regulation; Homocysteine; Hydrogen Sulfide; Male; Matrix Metalloproteinase 9; Phosphatidylinositol 3-Kinases; Primary Cell Culture; Proto-Oncogene Proteins c-akt; Pyridines; Rats; Rats, Sprague-Dawley; Signal Transduction; Thiazoles; Venous Thrombosis | 2017 |
[Antiembolic Stockings - Great Effects in Edoxaban Approval Studies].
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Combined Modality Therapy; Drug Approval; Evidence-Based Medicine; Germany; Guideline Adherence; Postoperative Complications; Pyridines; Stockings, Compression; Thiazoles; Thromboembolism; Venous Thrombosis | 2017 |
Study protocol for the dabigatran, apixaban, rivaroxaban, edoxaban, warfarin comparative effectiveness research study.
Topics: Anticoagulants; Antithrombins; Comparative Effectiveness Research; Dabigatran; Factor Xa Inhibitors; Humans; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Research Design; Rivaroxaban; Thiazoles; Venous Thrombosis; Warfarin | 2018 |
Comparison of Direct Oral Anticoagulants and Warfarin in the Treatment of Deep Venous Thrombosis in the Chronic Phase.
Topics: Administration, Oral; Aged; Anticoagulants; Antithrombins; Chronic Disease; Dabigatran; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Female; Humans; Male; Pyrazoles; Pyridines; Pyridones; Recurrence; Thiazoles; Treatment Outcome; Ultrasonography; Venous Thrombosis; Warfarin | 2018 |
Double venous compression due to duplicated inferior vena cava-induced right common iliac vein thrombosis.
Topics: Chest Pain; Constriction, Pathologic; Factor Xa Inhibitors; Female; Humans; Iliac Vein; Middle Aged; Pyridines; Thiazoles; Thrombolytic Therapy; Tomography, X-Ray Computed; Treatment Outcome; Vena Cava, Inferior; Venous Thrombosis | 2018 |
Edoxaban (Savaysa) for the Prevention of Thromboembolic Events.
Topics: Atrial Fibrillation; Cost-Benefit Analysis; Factor Xa Inhibitors; Humans; Pulmonary Embolism; Pyridines; Stroke; Thiazoles; Treatment Outcome; Venous Thrombosis | 2018 |
Edoxaban for the treatment of cancer associated venous thromboembolism as an alternative to low-molecular-weight-heparin.
Topics: Anticoagulants; Heparin; Heparin, Low-Molecular-Weight; Humans; Pyridines; Thiazoles; Venous Thromboembolism; Venous Thrombosis | 2018 |
Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH.
Topics: Administration, Oral; Anticoagulants; Antithrombins; Dabigatran; Dalteparin; Factor Xa Inhibitors; Hemorrhage; Humans; Multicenter Studies as Topic; Neoplasms; Observational Studies as Topic; Patient Acceptance of Health Care; Prospective Studies; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Recurrence; Rivaroxaban; Thiazoles; Venous Thromboembolism; Venous Thrombosis | 2018 |
Outcome of Direct Oral Anticoagulant Treatment for Acute Lower Limb Deep Venous Thrombosis After Total Knee Arthroplasty Or Total Hip Arthroplasty.
Topics: Administration, Oral; Aged; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Factor Xa Inhibitors; Female; Humans; Lower Extremity; Male; Middle Aged; Postoperative Complications; Pyrazoles; Pyridines; Pyridones; Thiazoles; Venous Thrombosis | 2019 |
Topics: Anticoagulants; Antithrombins; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Neoplasms; Perioperative Care; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Venous Thromboembolism; Venous Thrombosis | 2018 |
Direct oral anticoagulant successfully used to treat an adult nephrotic patient complicated with portal vein thrombosis.
Topics: Administration, Oral; Adult; Anticoagulants; Chemical and Drug Induced Liver Injury; Factor Xa Inhibitors; Humans; Male; Nephrotic Syndrome; Portal Vein; Pyridines; Thiazoles; Treatment Outcome; Venous Thrombosis | 2019 |
Edoxaban (Lixiana°).
Topics: Anticoagulants; Atrial Fibrillation; Chemical and Drug Induced Liver Injury; Factor Xa Inhibitors; Hemorrhage; Humans; International Normalized Ratio; Pulmonary Embolism; Pyridines; Stroke; Thiazoles; Venous Thrombosis; Warfarin | 2017 |
Deep Venous Thrombosis with Decreased Cerebral Blood Flow to the Thalamus was Completely Restored by Factor Xa Inhibitor.
Topics: Blood Coagulation; Cerebral Angiography; Cerebrovascular Circulation; Computed Tomography Angiography; Diffusion Magnetic Resonance Imaging; Factor Xa Inhibitors; Female; Humans; Intracranial Thrombosis; Male; Middle Aged; Phlebography; Pyridines; Thalamus; Thiazoles; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Venous Thrombosis | 2019 |
Paradoxical Brain Embolism Caused by Isolated Pulmonary Arteriovenous Fistula Successfully Treated with Recombinant Tissue Plasminogen Activator.
Topics: Aged, 80 and over; Arteriovenous Fistula; Cerebral Angiography; Computed Tomography Angiography; Diffusion Magnetic Resonance Imaging; Embolism, Paradoxical; Embolization, Therapeutic; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Humans; Intracranial Embolism; Magnetic Resonance Angiography; Pulmonary Artery; Pulmonary Veins; Pyridines; Recombinant Proteins; Thiazoles; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis | 2019 |
Impact of antithrombin deficiency on efficacy of edoxaban and antithrombin-dependent anticoagulants, fondaparinux, enoxaparin, and heparin.
Topics: Animals; Anticoagulants; Antithrombin III; Blood Coagulation Tests; Enoxaparin; Factor Xa Inhibitors; Female; Fondaparinux; Gene Deletion; Hemostasis; Male; Mice; Mice, Inbred C57BL; Polysaccharides; Pyridines; Thiazoles; Venous Thrombosis | 2013 |
Retrospective comparison of three thromboprophylaxis agents, edoxaban, fondaparinux, and enoxaparin, for preventing venous thromboembolism in total knee arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Dose-Response Relationship, Drug; Enoxaparin; Female; Fondaparinux; Humans; Incidence; Knee Joint; Male; Osteoarthritis, Knee; Polysaccharides; Pyridines; Retrospective Studies; Thiazoles; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis | 2014 |
[Edoxaban is safer than vitamin K antagonists].
Topics: Administration, Oral; Anticoagulants; Hemorrhage; Humans; Pulmonary Embolism; Pyridines; Randomized Controlled Trials as Topic; Secondary Prevention; Thiazoles; Venous Thrombosis; Vitamin K; Warfarin | 2013 |
Severe upper gastrointestinal bleeding in extraluminal diverticula in the third part of the duodenum.
Topics: Aged; Anticoagulants; Colonoscopes; Diverticulum; Duodenal Diseases; Duodenoscopy; Gastrointestinal Hemorrhage; Humans; Male; Pyridines; Severity of Illness Index; Thiazoles; Venous Thrombosis | 2014 |
Treatment of venous thrombosis with an oral direct factor Xa inhibitor edoxaban by single and multiple administrations in rats.
Topics: Administration, Oral; Animals; Anticoagulants; Antithrombin III; Disease Models, Animal; Drug Administration Schedule; Enoxaparin; Factor Xa Inhibitors; Fondaparinux; Male; Peptide Hydrolases; Polysaccharides; Pyridines; Rats; Rats, Wistar; Thiazoles; Venous Thrombosis | 2014 |
Elevated soluble platelet glycoprotein VI is a useful marker for DVT in postoperative patients treated with edoxaban.
Topics: Aged; Biomarkers; Factor Xa Inhibitors; Female; Fibrin Fibrinogen Degradation Products; Humans; Male; Middle Aged; Orthopedic Procedures; Platelet Membrane Glycoproteins; Postoperative Complications; Pyridines; Risk Factors; Thiazoles; Time Factors; Treatment Outcome; Venous Thrombosis | 2014 |
[Your patient needs an antithrombotic drug. Venous thrombosis of the leg: how and how long anticoagulation?].
Topics: Administration, Oral; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Substitution; Fibrinolytic Agents; General Practice; Heparin, Low-Molecular-Weight; Humans; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Venous Thrombosis | 2015 |
Factor Xa Inhibitor Suppresses the Release of Phosphorylated HSP27 from Collagen-Stimulated Human Platelets: Inhibition of HSP27 Phosphorylation via p44/p42 MAP Kinase.
Topics: Aged; Blood Platelets; Collagen; Factor Xa Inhibitors; Female; Healthy Volunteers; HSP27 Heat-Shock Proteins; Humans; Male; MAP Kinase Signaling System; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Platelet Activation; Platelet Aggregation; Pyridines; Rivaroxaban; Thiazoles; Venous Thrombosis | 2016 |
[IQWiG confirms significant additional applications for edoxaban ].
Topics: Adult; Anticoagulants; Atrial Fibrillation; Drug Approval; Germany; Humans; National Health Programs; Pulmonary Embolism; Pyridines; Stroke; Thiazoles; Thromboembolism; Venous Thrombosis | 2015 |
Edoxaban: a new oral direct factor xa inhibitor.
Topics: Administration, Oral; Animals; Anticoagulants; Atrial Fibrillation; Blood Coagulation; Clinical Trials as Topic; Factor Xa Inhibitors; Humans; Pyridines; Rabbits; Rats; Stroke; Thiazoles; Venous Thrombosis | 2011 |
In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Topics: Animals; Anticoagulants; Binding Sites; Cattle; Crystallography, X-Ray; Dogs; Drug Design; Electrocardiography; Fibrinolytic Agents; Guinea Pigs; Humans; Hydrogen-Ion Concentration; Hypotension; In Vitro Techniques; Ketones; Models, Molecular; Molecular Structure; Oligopeptides; Platelet Aggregation; Rabbits; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Thrombin; Trypsin; Venous Thrombosis | 2005 |
Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.
Topics: Amino Acid Chloromethyl Ketones; Animals; Anticoagulants; Antithrombins; Arteriovenous Shunt, Surgical; Bleeding Time; Disease Models, Animal; Dose-Response Relationship, Drug; Enoxaparin; Factor Xa Inhibitors; Fibrinolytic Agents; Hemostatics; Heparin; Male; Oligopeptides; Rabbits; Serine Proteinase Inhibitors; Thiazoles; Thrombin; Thrombosis; Venous Thrombosis | 2000 |